Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together Ended

2024-518103-21-00 Healthy volunteer trial 3 2025-06-30
Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants. Ended

2025-520736-41-00 No medical condition 2 2025-06-17
Bioequivalence clinical trial of two formulations of dapagliflozin/metformin Ended

2024-514050-75-01 Healthy volunteers 2 2025-06-04
Bioequivalence of One Tablet of Gliclazide MR 90 mg (S005190) and One and a Half Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy P… Ended

2024-519567-18-00 No medical condition. 2 2025-06-02
Bioequivalence of One Tablet of Gliclazide MR 120 mg (S005190) and Two Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy Participant… Ended

2024-519470-39-00 No medical condition. 2 2025-05-30
Investigate Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Tampons and Lubricants in Healthy Female Partic… Ended

2025-520517-32-00 No medical condition. 3 2025-05-29
Investigation of Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Miconazole in Healthy Female Participants. Ended

2025-520516-33-00 No medical condition. 3 2025-05-28
A trial to learn about how multiple doses of itraconazole change how AZD5004 moves throughout the body over time in healthy adults and how m… Ended

2024-518467-35-00 Not applicable, healthy volunteers 3 2025-05-28
Bioequivalence of One Tablet of Gliclazide MR 120 mg (S005190) and Two Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy Participant… Ended

2024-519250-37-00 No medical condition. 2 2025-05-27
A study to test how well multiple doses of BI 3810477 are tolerated by healthy adults. Ended

2024-519327-20-00 Healthy volunteer trial 3 2025-05-21
A study in healthy people to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed wit… Ended

2025-520813-29-00 Healthy volunteer trial 3 2025-05-21
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food Ended

2024-519615-34-00 healthy volunteer trial 3 2025-05-19
A multicentric, open-label, non-randomized study to evaluate the pharmacokinetic, safety and tolerability of ITF2357 given as an oral single… Ended

2024-513577-43-00 Participants with normal hepatic function 3 2025-05-16
A Study on Oral and Intranasal Forms in Healthy Volunteers using Pharmacokinetic Modeling Ended

2024-515461-34-00 healthy volunteers 3 2025-05-14
Phase 1 clinical trial to evaluate the safety, tolerability and pharmacokinetics of multiple daily doses of IM-250 in healthy volunteers. Ended

2024-519482-22-00 Healthy Volunteers 3 2025-04-30
A study in healthy people to test whether erythromycin influences the amount of BI 1291583 in the blood. Ended

2024-515795-12-00 Healthy volunteer trial 3 2025-04-29
Multiple-Dose Study on the Bioequivalence of One Tablet of Gliclazide MR 120 mg (S005190) and Two Tablets of Gliclazide MR 60 mg (Diaprel® M… Ended

2024-519640-32-00 No medical condicion. 2 2025-04-22
SGL-TX-MR Study: The acute effect of SGLT2i on kidney transplant oxygen levels. Ended

2024-513765-40-00 Kidney transplant recipients 4 2025-03-27
Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227 Ended

2024-518734-87-00 No medical condition. 3 2025-03-25
A study in healthy men to test whether food influences the amount of BI 3731579 in the blood Ended

2024-517895-39-00 Healthy volunteer trial 3 2025-03-17
Bioequivalence of Ruxolitinib 25 mg Tablets in Healthy Participants Under Fasting Conditions Ended

2025-520716-34-00 No medical condition. 2 2025-03-17
Phase I clinical trial to evaluate the pharmacokinetics, safety and tolerability of repeated topical application of PARENTIDE in healthy vol… Ended

2024-516833-11-00 Healthy volunteers 3 2025-03-12
Bioequivalence of Lisdexamfetamine dimesylate 70 mg Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-516826-79-00 No medical condition. 2 2025-03-10
Bioequivalence of Lisdexamfetamine dimesylate 20 mg Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-516827-14-00 No medical condition. 2 2025-03-10